GNH USA

Europe — EMA

Octagam (Human Normal Immunoglobulin)

GNH USA supplies Octagam (Human Normal Immunoglobulin), a immunoglobulin therapy for primary immunodeficiency and autoimmune neuropathies.

Human Normal Immunoglobulin

Request sourcing

1
Pack/s

What is Human Normal Immunoglobulin?

Human Normal Immunoglobulin, the active ingredient in Octagam, is an immunoglobulin presented as a liquid for intravenous use. It replaces missing antibodies and is used to treat immune deficiencies and certain autoimmune conditions in both children and adults.

GNH USA supplies Octagam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

What is Human Normal Immunoglobulin used for?

Octagam is an immunoglobulin therapy that acts on disorders of the immune system. It is indicated for: - Primary immunodeficiency diseases: provides replacement IgG to reduce infection frequency. - Chronic inflammatory demyelinating polyneuropathy (CIDP): helps improve muscle strength and functional ability. - Multifocal motor neuropathy (MMN): reduces weakness and improves motor function. - Immune thrombocytopenia (ITP) refractory to other treatments: raises platelet counts and decreases bleeding risk.

What are the side effects of Human Normal Immunoglobulin?

Adverse reactions to Octagam may vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate pain often occurring during or after infusion. - Fever: transient rise in body temperature. - Chills: shaking sensations during infusion. - Nausea: mild stomach upset. - Fatigue: feeling of tiredness post‑infusion. - Injection site reactions: redness or swelling at the IV site.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Thromboembolic events: blood clots that may affect circulation. - Acute renal failure: sudden loss of kidney function. - Hemolytic anemia: destruction of red blood cells. - Aseptic meningitis: inflammation of the meninges without infection. - Severe hypotension: dangerous drop in blood pressure.

What precautions apply to Human Normal Immunoglobulin?

Before using Octagam, consider the following safety measures: - Assess renal function: evaluate kidney health prior to initiation. - Screen for thrombotic risk: identify patients with a history of clotting disorders. - Monitor for IgA deficiency: patients lacking IgA may develop anti‑IgA antibodies. - Observe during infusion: watch for signs of anaphylaxis or severe reactions. - Adjust infusion rate: slower rates may reduce adverse events. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Human Normal Immunoglobulin interact with?

Octagam can interact with other medicines, affecting safety or efficacy.

Major Interactions (Avoid): - Live vaccines: concurrent use may reduce vaccine effectiveness and increase infection risk. - High‑dose aspirin or NSAIDs: may increase bleeding risk when combined with immunoglobulin therapy.

Moderate Interactions (Monitor Closely): - Immunosuppressants (e.g., cyclophosphamide, azathioprine): may alter immune response and require dose adjustments. - Anticoagulants (e.g., warfarin): monitor INR levels as immunoglobulin can affect coagulation. - Diuretics: may influence fluid balance during infusion. - Monoclonid­e‑          

Frequently asked questions

What is Octagam used for?+
Octagam is a sterile liquid preparation of human normal immunoglobulin used to replace deficient antibodies in primary immunodeficiency diseases and to modulate immune activity in certain autoimmune neuropathies such as chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy.
How does Human Normal Immunoglobulin work in Octagam?+
The pooled IgG antibodies in Octagam bind to a wide range of antigens, neutralising pathogens and interacting with immune‑cell receptors, complement and cytokines. This broad activity reduces auto‑antibody production, enhances opsonisation of microbes and helps restore normal immune regulation.
What is the usual dose of Octagam?+
The dosage of Octagam is individualized by the prescribing clinician based on the patient’s weight, indication and clinical response. Healthcare providers calculate the infusion volume and rate according to established guidelines and adjust as needed for safety and efficacy.
Is Octagam safe to use during pregnancy or breastfeeding?+
Human normal immunoglobulin is classified as a Category C product; it may be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Limited data exist for breastfeeding, and clinicians usually consider the benefits to the mother against possible exposure to the infant.
How do I order Octagam from GNH USA?+
To request Octagam, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics) and necessary import documentation.
How does Octagam compare with other intravenous immunoglobulin products?+
Octagam is an EU‑sourced, 10% liquid immunoglobulin similar in composition to other IVIG brands such as Privigen or Gamunex. Differences may include manufacturing processes, stabilisers, and approved indications. Clinical efficacy is comparable, while safety profiles can vary slightly based on excipients and infusion tolerability.
What are the storage and handling requirements for Octagam?+
Octagam must be stored refrigerated at 2 °C to 8 °C, protected from light, and must never be frozen or shaken. Before use, inspect the solution for particulates or discoloration and allow it to reach room temperature if required by the infusion protocol.
How is Octagam administered?+
Octagam is given by intravenous infusion under the supervision of a qualified healthcare professional. The infusion rate is started slowly and may be increased according to patient tolerance, with vital signs monitored throughout the procedure.
What are the most serious risks associated with Octagam?+
Serious adverse events include anaphylaxis, thromboembolic complications, acute renal failure, hemolytic anemia, aseptic meningitis and severe hypotension. Prompt recognition and management of these reactions are essential during and after infusion.
Who should not receive Octagam?+
Octagam is contraindicated in patients with a known severe IgA deficiency who have anti‑IgA antibodies, a history of anaphylactic reactions to immunoglobulin products, or uncontrolled hypercoagulable states. Clinicians should also avoid use in patients with active severe infections until the infection is controlled.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Human Normal Immunoglobulin
Route
Intravenous Use
Manufacturer
Octapharma (Ip) Sprl
Origin
EU

Related products

Beriglobin

Beriglobin

Human Normal Immunoglobulin

Csl Behring Gmbh
EU
Beriglobin P

Beriglobin P

Human Normal Immunoglobulin

Csl Behring Gmbh
EU
Beriglobina P

Beriglobina P

Human Normal Immunoglobulin

Csl Behring S.A.
EU
Clairyg

Clairyg

Human Normal Immunoglobulin

Lfb Biomedicaments
EU